Literature DB >> 15243330

[Hepatocellular carcinoma without cirrhosis in a patient with nonalcoholic steatohepatitis].

Rabia Bencheqroun1, Christophe Duvoux, Alain Luciani, Elie-Serge Zafrani, Daniel Dhumeaux.   

Abstract

All cases of hepatocellular carcinoma reported thus for in patients with nonalcoholic steatohepatitis have occurred on preexisting cirrhosis. We report the case of a 68-Year-old male patient with nonalcoholic steatohepatitis who developed hepatocellular carcinoma in the absence of cirrhosis. This observation suggests a possible relationship between nonalcoholic steatohepatitis and/or excess body weight, and hepatocellular carcinoma independent of cirrhosis. Further epidemiological studies are needed to evaluate the incidence of this association.

Entities:  

Mesh:

Year:  2004        PMID: 15243330     DOI: 10.1016/s0399-8320(04)94971-8

Source DB:  PubMed          Journal:  Gastroenterol Clin Biol        ISSN: 0399-8320


  5 in total

1.  Surgical outcomes for hepatocellular carcinoma in nonalcoholic fatty liver disease.

Authors:  Toshifumi Wakai; Yoshio Shirai; Jun Sakata; Pavel Vladimirovich Korita; Yoichi Ajioka; Katsuyoshi Hatakeyama
Journal:  J Gastrointest Surg       Date:  2011-04-22       Impact factor: 3.452

Review 2.  Nonalcoholic steatohepatitis-associated hepatocellular carcinoma: our case series and literature review.

Authors:  Yoshitaka Takuma; Kazuhiro Nouso
Journal:  World J Gastroenterol       Date:  2010-03-28       Impact factor: 5.742

3.  Significant cohort of non-alcoholic fatty liver disease with portal vein thrombosis in transplant waiting list.

Authors:  Metin Basaranoglu; Sonia M Najjar; Ali Ebag Demirbag; Hakan Senturk
Journal:  World J Hepatol       Date:  2016-03-08

4.  Epidemiology of primary and secondary liver cancers.

Authors:  Ashwin Ananthakrishnan; Veena Gogineni; Kia Saeian
Journal:  Semin Intervent Radiol       Date:  2006-03       Impact factor: 1.513

Review 5.  Non-alcoholic fatty liver disease: an emerging pathological spectrum.

Authors:  Elie Serge Zafrani
Journal:  Virchows Arch       Date:  2003-12-18       Impact factor: 4.064

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.